Rice v. Ivey et al

On August 15, 2024, plaintiff Nathaniel Rice filed a federal civil rights and wrongful death lawsuit in Alabama against Governor Kay Ivey, Corrections Commissioner John Q. Hamm, and the Alabama Department of Corrections. The complaint alleges that the defendants failed to provide adequate medical care for Rice's chronic Hepatitis C, leading to severe liver damage, cirrhosis, and an increased risk of death. The lawsuit claims the prison system delayed and denied necessary direct-acting antiviral treatment based on cost-containment policies rather than medical need, constituting deliberate indifference to a serious medical need in violation of the Eighth Amendment and Title II of the Americans with Disabilities Act.

The case remains in active litigation as of the filing date. The plaintiff seeks class-action certification, declaratory judgment that the treatment policy is unconstitutional, injunctive relief mandating immediate treatment, and compensatory and punitive damages for the prolonged suffering and permanent liver damage allegedly caused by the delayed care.

Whether the Alabama Department of Corrections' Hepatitis C treatment protocol, which allegedly prioritizes cost over medical necessity by restricting treatment to only the sickest inmates, constitutes deliberate indifference to a serious medical need in violation of the Eighth Amendment's prohibition against cruel and unusual punishment.

This lawsuit highlights systemic issues within the Alabama prison system, already under Department of Justice investigation for unconstitutional conditions. It challenges state correctional healthcare policies across the U.S., particularly the rationing of high-cost Hepatitis C medication. The case could force states to expand treatment access to thousands of incarcerated individuals, potentially setting a national precedent on the constitutional minimum for inmate medical care and adding pressure for broader prison healthcare reform amidst ongoing debates about mass incarceration and public health equity.